Propofol depresses cisplatin cytotoxicity via the inhibition of gap junctions

Zhang,Yuan; Wang,Xiyan; Wang,Qin; Ge,Hui; Tao,Liang

doi:10.3892/mmr.2016.5119

Propofol depresses cisplatin cytotoxicity via the inhibition of gap junctions

Authors:
- Yuan Zhang
- Xiyan Wang
- Qin Wang
- Hui Ge
- Liang Tao
View Affiliations

Affiliations: Department of Pharmacology, Zhongshan School of Medicine, Sun Yat‑Sen University, Guangzhou, Guangdong 510080, P.R. China, Tumor Research Institute, Xinjiang Medical University Affiliated Tumor Hospital, Urumqi, Xinjiang 830000, P.R. China
Published online on: April 13, 2016 https://doi.org/10.3892/mmr.2016.5119
Pages: 4715-4720

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The general anesthetic, propofol, affects chemotherapeutic activity, however, the mechanism underlying its effects remains to be fully elucidated. Our previous study showed that tramadol and flurbiprofen depressed the cytotoxicity of cisplatin via the inhibition of gap junction (GJ) intercellular communication (GJIC) in connexin (Cx)32 HeLa cells. The present study investigated whether the effects of propofol on the cytotoxicity of cisplatin were mediated by GJ in U87 glioma cells and Cx26‑transfected HeLa cells. Standard colony formation assay was used to determine the cytotoxicity of cisplatin. Parachute dye coupling assay was used to measure GJ function, and western blot analysis was used to determine the expression levels of Cx32. The results revealed that exposure of the U87 glioma cells and the Cx26-transfected HeLa cells to cisplatin for 1 h reduced clonogenic survival in low density cultures (without GJs) and high density cultures (with GJs). However, the toxic effect was higher in the high density culture. In addition, pretreatment of the cells with propofol significantly reduced cisplatin‑induced cytotoxicity, but only in the presence of functional GJs. Furthermore, propofol significantly inhibited dye coupling through junctional channels, and a long duration of exposure of the cells to propofol downregulated the expression levels of Cx43 and Cx26. These results demonstrated that the inhibition of GJIC by propofol affected the therapeutic efficacy of chemotherapeutic drugs. The present study provides evidence of a novel mechanism underlying the effects of analgesics in counteracting chemotherapeutic efficiency.

View Figures

View References

1	Sosinsky GE and Nicholson BJ: Structural organization of gap junction channels. Biochim Biophys Acta. 1711:99–125. 2005. View Article : Google Scholar : PubMed/NCBI
2	Harris AL: Connexin channel permeability to cytoplasmic molecules. Prog Biophys Mol Biol. 94:120–143. 2007. View Article : Google Scholar : PubMed/NCBI
3	Maeda S and Tsukihara T: Structure of the gap junction channel and its implications for its biological functions. Cell Mol Life Sci. 68:1115–1129. 2011. View Article : Google Scholar
4	Vinken M, Vanhaecke T, Papeleu P, Snykers S, Henkens T and Rogiers V: Connexins and their channels in cell growth and cell death. Cell Signal. 18:592–600. 2006. View Article : Google Scholar
5	Cronier L, Crespin S, Strale PO, Defamie N and Mesnil M: Gap junctions and cancer: New functions for an old story. Antioxid Redox Signal. 11:323–338. 2009. View Article : Google Scholar
6	Kandouz M and Batist G: Gap junctions and connexins as therapeutic targets in cancer. Expert Opin Ther Targets. 14:681–692. 2010. View Article : Google Scholar : PubMed/NCBI
7	Naus CC and Laird DW: Implications and challenges of connexin connections to cancer. Nat Rev Cancer. 10:435–441. 2010. View Article : Google Scholar : PubMed/NCBI
8	Wang Q, You T, Yuan D, Han X, Hong X, He B, Wang L, Tong X, Tao L and Harris AL: Cisplatin and oxaliplatin inhibit gap junctional communication by direct action and by reduction of connexin expression, thereby counteracting cytotoxic efficacy. J Pharmacol Exp Ther. 333:903–911. 2010. View Article : Google Scholar : PubMed/NCBI
9	Jensen R and Glazer PM: Cell-interdependent cisplatin killing by Ku/DNA-dependent protein kinase signaling transduced through gap junctions. Proc Natl Acad Sci USA. 101:6134–6139. 2004. View Article : Google Scholar : PubMed/NCBI
10	Azzam EI, de Toledo SM and Little JB: Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from alpha-particle irradiated to nonirradiated cells. Proc Natl Acad Sci USA. 98:473–478. 2001.
11	Mesnil M, Piccoli C, Tiraby G, Willecke K and Yamasaki H: Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. Proc Natl Acad Sci USA. 93:1831–1835. 1996. View Article : Google Scholar : PubMed/NCBI
12	Weiser TG, Regenbogen SE, Thompson KD, Haynes AB, Lipsitz SR, Berry WR and Gawande AA: An estimation of the global volume of surgery: A modelling strategy based on available data. Lancet. 372:139–144. 2008. View Article : Google Scholar : PubMed/NCBI
13	Zhu M, Chen J, Yin H, Jiang H, Wen M and Miao C: Propofol protects human umbilical vein endothelial cells from cisplatin-induced injury. Vascul Pharmacol. 61:72–79. 2014. View Article : Google Scholar : PubMed/NCBI
14	Taheri Moghadam G, Hosseini-Zijoud SM, Heidary Shayesteh T, Ghasemi H and Ranjbar A: Attenuation of cisplathin-induced toxic oxidative stress by propofol. Anesth Pain Med. 4:e142212014. View Article : Google Scholar
15	Wentlandt K, Carlen PL, Kushnir M, Naus CC and El-Beheiry H: General anesthetics attenuate gap junction coupling in P19 cell line. J Neurosci Res. 81:746–752. 2005. View Article : Google Scholar : PubMed/NCBI
16	Huang F, Li S, Gan X, Wang R and Chen Z: Propofol inhibits gap junctions by attenuating sevoflurane-induced cytotoxicity against rat liver cells in vitro. Eur J Anaesthesiol. 31:219–224. 2014. View Article : Google Scholar
17	He B, Tong X, Wang L, Wang Q, Ye H, Liu B, Hong X, Tao L and Harris AL: Tramadol and flurbiprofen depress the cytotoxicity of cisplatin via their effects on gap junctions. Clin Cancer Res. 15:5803–5810. 2009. View Article : Google Scholar : PubMed/NCBI
18	Zhao Y, Liu B, Wang Q, Yuan D, Yang Y, Hong X, Wang X and Tao L: Propofol depresses the cytotoxicity of X-ray irradiation through inhibition of gap junctions. Anesth Analg. 112:1088–1095. 2011. View Article : Google Scholar : PubMed/NCBI
19	Koreen IV, Elsayed WA, Liu YJ and Harris AL: Tetracycline-regulated expression enables purification and functional analysis of recombinant connexin channels from mammalian cells. Biochem J. 383:111–119. 2004. View Article : Google Scholar : PubMed/NCBI
20	Papazisis KT, Geromichalos GD, Dimitriadis KA and Kortsaris AH: Optimization of the sulforhodamine B colori-metric assay. J Immunol Methods. 208:151–158. 1997. View Article : Google Scholar
21	Goldberg GS, Bechberger JF and Naus CC: A pre-loading method of evaluating gap junctional communication by fluorescent dye transfer. Biotechniques. 18:490–497. 1995.PubMed/NCBI
22	Hong X, Wang Q, Yang Y, Zheng S, Tong X, Zhang S, Tao L and Harris AL: Gap junctions propagate opposite effects in normal and tumor testicular cells in response to cisplatin. Cancer Lett. 317:165–171. 2012. View Article : Google Scholar
23	White M and Kenny GN: Intravenous propofol anaesthesia using a computerised infusion system. Anaesthesia. 45:204–209. 1990. View Article : Google Scholar : PubMed/NCBI
24	Wang Y, Wang Q, Zhang S, Zhang Y and Tao L: Baicalein increases the cytotoxicity of cisplatin by enhancing gap junction intercellular communication. Mol Med Rep. 10:515–521. 2014.PubMed/NCBI
25	Mesnil M, Crespin S, Avanzo JL and Zaidan-Dagli ML: Defective gap junctional intercellular communication in the carcinogenic process. Biochim Biophys Acta. 1719:125–145. 2005. View Article : Google Scholar : PubMed/NCBI
26	Loewenstein WR and Kanno Y: Intercellular communication and the control of tissue growth: Lack of communication between cancer cells. Nature. 209:1248–1249. 1966. View Article : Google Scholar : PubMed/NCBI
27	Leithe E, Sirnes S, Omori Y and Rivedal E: Downregulation of gap junctions in cancer cells. Crit Rev Oncog. 12:225–256. 2006. View Article : Google Scholar
28	Plante I, Stewart MK, Barr K, Allan AL and Laird DW: Cx43 suppresses mammary tumor metastasis to the lung in a Cx43 mutant mouse model of human disease. Oncogene. 30:1681–1692. 2011. View Article : Google Scholar
29	Krutovskikh VA, Piccoli C and Yamasaki H: Gap junction intercellular communication propagates cell death in cancerous cells. Oncogene. 21:1989–1999. 2002. View Article : Google Scholar : PubMed/NCBI
30	Czyz J: The stage-specific function of gap junctions during tumourigenesis. Cell Mol Biol Lett. 13:92–102. 2008. View Article : Google Scholar
31	Kanczuga-Koda L, Sulkowska M, Koda M, Rutkowski R and Sulkowski S: Increased expression of gap junction protein-connexin 32 in lymph node metastases of human ductal breast cancer. Folia Histochem Cytobiol. 45(Suppl 1): S175–S180. 2007.
32	Saito-Katsuragi M, Asada H, Niizeki H, Katoh F, Masuzawa M, Tsutsumi M, Kuniyasu H, Ito A, Nojima H and Miyagawa S: Role for connexin 26 in metastasis of human malignant melanoma: Communication between melanoma and endothelial cells via connexin 26. Cancer. 110:1162–1172. 2007. View Article : Google Scholar : PubMed/NCBI
33	Tang N, Wang Q, Wu DP, Zhang SZ, Zhang Y and Tao L: Differential effects of paclitaxel and docetaxel on gap junctions affects their cytotoxicities in transfected HeLa cells. Mol Med Rep. 8:638–644. 2013.PubMed/NCBI